PMAM
ORIAW

Picton Mahoney Asset Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Picton Mahoney Asset Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,400
Closed -$28K – 1131
2021
Q4 		$28K Hold
28,400
– – ﹤0.01% 890
2021
Q3 		$25K Buy
+28,400
New +$36.9K ﹤0.01% 827

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Picton Mahoney Asset Management's ORIAW Position: Q1 2022 in Review

Picton Mahoney Asset Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q1 2022, closing a stake of 28,400 shares — an estimated $28K sold.

Picton Mahoney Asset Management first reported a position in ORIAW in Q3 2021 and held it in 2 quarters. The position peaked at $28K in Q4 2021. 30 funds tracked by Wall St. Rank hold ORIAW as of Q1 2022.

  • Picton Mahoney Asset Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q1 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 28,400 Orion Biotech Opportunities Corp. Warrant shares in Q1 2022, an estimated $28K.
  • Picton Mahoney Asset Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 2 quarters.
  • Picton Mahoney Asset Management's Orion Biotech Opportunities Corp. Warrant position peaked at $28K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q1 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2022, filed 11 May 2022.